A Comprehensive Tutorial on in Vitro Characterization of New Photosensitizers for Photodynamic Antitumor Therapy and Photodynamic Inactivation of Microorganisms
Overview
Biotechnology
General Medicine
Affiliations
In vitro research performed on eukaryotic or prokaryotic cell cultures usually represents the initial step for characterization of a novel photosensitizer (PS) intended for application in photodynamic therapy (PDT) of cancer or photodynamic inactivation (PDI) of microorganisms. Although many experimental steps of PS testing make use of the wide spectrum of methods readily employed in cell biology, special aspects of working with photoactive substances, such as the autofluorescence of the PS molecule or the requirement of light protection, need to be considered when performing in vitro experiments in PDT/PDI. This tutorial represents a comprehensive collection of operative instructions, by which, based on photochemical and photophysical properties of a PS, its uptake into cells, the intracellular localization and photodynamic action in both tumor cells and microorganisms novel photoactive molecules may be characterized for their suitability for PDT/PDI. Furthermore, it shall stimulate the efforts to expand the convincing benefits of photodynamic therapy and photodynamic inactivation within both established and new fields of applications and motivate scientists of all disciplines to get involved in photodynamic research.
Saliva-derived components can enhance the performance of toluidine blue in photodynamic therapy.
Macri N, Dias L, Pavarina A, Siqueira W, Sperandio F Front Pharmacol. 2025; 16:1538520.
PMID: 40017593 PMC: 11865188. DOI: 10.3389/fphar.2025.1538520.
Vermathen M, Kampfer T, Nuoffer J, Vermathen P Pharmaceutics. 2023; 15(9).
PMID: 37765292 PMC: 10537485. DOI: 10.3390/pharmaceutics15092324.
Combinatorial Polydopamine-Liposome Nanoformulation as an Effective Anti-Breast Cancer Therapy.
Lu W, Liu W, Hu A, Shen J, Yi H, Cheng Z Int J Nanomedicine. 2023; 18:861-879.
PMID: 36844433 PMC: 9944797. DOI: 10.2147/IJN.S382109.
Alpatova V, Rys E, Kononova E, Khakina E, Markova A, Shibaeva A Molecules. 2022; 27(19).
PMID: 36234729 PMC: 9572311. DOI: 10.3390/molecules27196200.
Parietin Cyclodextrin-Inclusion Complex as an Effective Formulation for Bacterial Photoinactivation.
Ayoub A, Gutberlet B, Preis E, Abdelsalam A, Abu Dayyih A, Abdelkader A Pharmaceutics. 2022; 14(2).
PMID: 35214089 PMC: 8875783. DOI: 10.3390/pharmaceutics14020357.